The revolutionary treatment has been shown to significantly shrink tumours in almost half of patients with the disease
Thousands of women with ovarian cancer could benefit from a revolutionary drug combination after it was shown to significantly shrink tumours in almost half of patients with the disease.
The new treatment blocks tumour growth, helping keep the disease at bay for years. Experts said the “fantastic” and “very exciting” results from clinical trials of the drug combination, presented at the world’s largest cancer conference this weekend, showed it was “far more effective” than any available option for patients.
About Author
More Stories
Revealed: Chinese researchers can access half a million UK GP records
Brisk walking linked to lower risk of heart rhythm problems, study finds
How RFK Jr’s mixed messages on vaccines are impacting scientific research – podcast